US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Antibody Technologies Market Research Reports & Industry Analysis

RSS Feeds

Antibody Technologies Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2016
1/18/2016 | published by: DelveInsight
... currently active CAR-T cell products in research and development. The Report covers the 40+ companies which are active in this field including 27 leading companies with 101 products targeting 44 different antigens and 24 different ...  |  read more...
USD 2,450
Global and Chinese Votumumab Industry, 2016 Market Research Report
1/20/2016 | published by: Prof-Research
... report provides key statistics on the market status of the Votumumab manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview ...  |  read more...
USD 2,900
Global Anti-CD20 Monoclonal Antibodies Industry 2016 Market Research Report
1/21/2016 | published by: QYResearch Group
... the industry including definitions, classifications, applications and industry chain structure. The Anti-CD20 Monoclonal Antibodies market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development ...  |  read more...
USD 2,800
Global Monoclonal Antibodies Drug Delivery Industry 2016 Market Research Report
1/22/2016 | published by: QYResearch Group
... overview of the industry including definitions, classifications, applications and industry chain structure. The Monoclonal Antibodies Drug Delivery market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development ...  |  read more...
USD 2,800
Global Monoclonal Antibody Diagnostic Reagents Industry 2016 Market Research Report
1/26/2016 | published by: QYResearch Group
... overview of the industry including definitions, classifications, applications and industry chain structure. The Monoclonal Antibody Diagnostic Reagents market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development ...  |  read more...
USD 2,800
Anti-CD19 Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ...  |  read more...
USD 1,250
Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ...  |  read more...
USD 1,250
Anti-CD3 Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Anti-CD4 Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Anti-CD52 Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Anti-CD6 Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Anti-CD70 Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Anti-CD95 Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Anti-Dickkopf-1 (Dkk-1) Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ...  |  read more...
USD 1,250
Aurora A Kinase Inhibitors -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent ...  |  read more...
USD 1,250
What’s Driving the In Vitro Diagnostics Industry? - The Road to 2020 and Beyond: Alternative Scenarios of the Future IVD Market - Business-as-Usual, Economic Austerity, Technological Breakthroughs 2015-2020
1/6/2016 | published by: VPGMarketResearch.com
... markers - Analyzes applications of emerging diagnostic technologies - Forecasts sales of major tumor markers by country and market segment - Profiles leading market players and potential entrants - Suggests alternative business expansion strategies for ...  |  read more...
USD 14,500
Combination Antibody Therapy for Cancer Treatment Overview
1/1/2016 | published by: CHI Insight Pharma Reports
... sales, and if their performance has not been the unalloyed triumph that was foreseen at their inception, they have, at least in some instances, produced impressive gains in patient response. Today they are one of ...  |  read more...
USD 2,495
Anti-CD22 Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Anti-CD25 Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Anti-CD28 Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Anti-CD30 Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Anti-CD33 Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Anti-CD37 Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Anti-CD38 Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
< prev 1    3  4  5  6  7  8  9  10